thymidine has been researched along with Disease Exacerbation in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is limited data on the efficacy and outcome of telbivudine (LdT) therapy in patients with chronic hepatitis B and compensated cirrhosis." | 9.19 | Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis. ( Chang, KC; Chen, CH; Chiu, KW; Hu, TH; Hung, CH; Lee, CM; Lin, MT; Tsai, MC; Tseng, PL; Yen, YH; Yu, HC, 2014) |
| "The aims of this study were to evaluate the possibility of using (11)C-methionine ((11)C-MET) and (11)C-4'-thiothymidine ((11)C-4DST) whole-body PET/CT for the imaging of amino acid metabolism and DNA synthesis, respectively, when searching for bone marrow involvement in patients with multiple myeloma (MM) and to compare these findings with those for (18)F-FDG PET/CT and aspiration cytology." | 7.81 | Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma. ( Hagiwara, S; Hirai, R; Inoue, T; Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miwa, A; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J, 2015) |
| "There is limited data on the efficacy and outcome of telbivudine (LdT) therapy in patients with chronic hepatitis B and compensated cirrhosis." | 5.19 | Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis. ( Chang, KC; Chen, CH; Chiu, KW; Hu, TH; Hung, CH; Lee, CM; Lin, MT; Tsai, MC; Tseng, PL; Yen, YH; Yu, HC, 2014) |
| "Serum IL-21 levels were measured by enzyme immunoassay in 75 HBeAg-positive chronic hepatitis B (CHB) patients undergoing telbivudine treatment." | 5.16 | High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. ( Abbott, WG; Dong, YH; Hou, JL; Huang, X; Jiang, XT; Li, YY; Liu, ZH; Ma, SW; Naoumov, NV; Sun, J; Sun, XF; Tang, LB; Zhang, YX, 2012) |
| "The aims of this study were to evaluate the possibility of using (11)C-methionine ((11)C-MET) and (11)C-4'-thiothymidine ((11)C-4DST) whole-body PET/CT for the imaging of amino acid metabolism and DNA synthesis, respectively, when searching for bone marrow involvement in patients with multiple myeloma (MM) and to compare these findings with those for (18)F-FDG PET/CT and aspiration cytology." | 3.81 | Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma. ( Hagiwara, S; Hirai, R; Inoue, T; Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miwa, A; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J, 2015) |
| " To examine changes in phosphorylated Smad3 signalling before and after anti-HBV therapies, we chose 27 patients with chronic hepatitis B who underwent baseline and follow-up biopsies at 52 weeks from the start of nucleoside analogue treatments (Lamivudine 100 mg daily or Telbivudine 600 mg daily)." | 3.80 | Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. ( Deng, YR; Jin, QL; Lian, ZX; Matsuzaki, K; Moritoki, Y; Murata, M; Niu, JQ; Tsuneyama, K; Yamaguchi, T; Yoshida, K, 2014) |
| "Twenty-one consecutive chronic hepatitis B patients experiencing severe acute exacerbation were treated with either telbivudine or entecavir." | 3.79 | On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study. ( Chang, MY; Chen, YC; Hsu, CW; Yeh, CT, 2013) |
| "Pravastatin was active only in medium with lipoprotein-deficient serum." | 2.68 | Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies. ( Angelin, B; Juliusson, G; Vitols, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC | 1 |
| Hsu, CW | 1 |
| Chang, MY | 1 |
| Yeh, CT | 1 |
| Park, YH | 1 |
| Kim, BK | 1 |
| Kim, JK | 1 |
| Kim, HC | 1 |
| Kim, DY | 1 |
| Park, JY | 1 |
| Han, KH | 1 |
| Kim, SU | 1 |
| Shin, SH | 1 |
| Hahn, KY | 1 |
| Ahn, SH | 1 |
| Deng, YR | 1 |
| Yoshida, K | 2 |
| Jin, QL | 1 |
| Murata, M | 2 |
| Yamaguchi, T | 1 |
| Tsuneyama, K | 1 |
| Moritoki, Y | 1 |
| Niu, JQ | 1 |
| Matsuzaki, K | 2 |
| Lian, ZX | 1 |
| Tsai, MC | 1 |
| Yu, HC | 1 |
| Hung, CH | 1 |
| Lee, CM | 1 |
| Chiu, KW | 1 |
| Lin, MT | 1 |
| Tseng, PL | 1 |
| Chang, KC | 1 |
| Yen, YH | 1 |
| Chen, CH | 1 |
| Hu, TH | 1 |
| Okasaki, M | 1 |
| Kubota, K | 1 |
| Minamimoto, R | 1 |
| Miyata, Y | 1 |
| Morooka, M | 1 |
| Ito, K | 1 |
| Ishiwata, K | 1 |
| Toyohara, J | 1 |
| Inoue, T | 1 |
| Hirai, R | 1 |
| Hagiwara, S | 1 |
| Miwa, A | 1 |
| Frick, LR | 1 |
| Rapanelli, M | 1 |
| Bussmann, UA | 1 |
| Klecha, AJ | 1 |
| Arcos, ML | 1 |
| Genaro, AM | 1 |
| Cremaschi, GA | 1 |
| Mallet, V | 1 |
| Vallet-Pichard, A | 1 |
| Pol, S | 1 |
| Mileshkin, L | 1 |
| Hicks, RJ | 1 |
| Hughes, BG | 1 |
| Mitchell, PL | 1 |
| Charu, V | 1 |
| Gitlitz, BJ | 1 |
| Macfarlane, D | 1 |
| Solomon, B | 1 |
| Amler, LC | 1 |
| Yu, W | 1 |
| Pirzkall, A | 1 |
| Fine, BM | 1 |
| Ma, SW | 1 |
| Huang, X | 1 |
| Li, YY | 1 |
| Tang, LB | 1 |
| Sun, XF | 1 |
| Jiang, XT | 1 |
| Zhang, YX | 1 |
| Sun, J | 1 |
| Liu, ZH | 1 |
| Abbott, WG | 1 |
| Dong, YH | 1 |
| Naoumov, NV | 1 |
| Hou, JL | 1 |
| Awazu, M | 1 |
| Omori, S | 1 |
| Ishikura, K | 1 |
| Hida, M | 1 |
| Fujita, H | 1 |
| Shao, H | 1 |
| Sun, D | 1 |
| Sun, SL | 1 |
| Cruze, JM | 1 |
| Bora, N | 1 |
| Kaplan, HJ | 1 |
| Terada, Y | 1 |
| Kobayashi, T | 1 |
| Kuwana, H | 1 |
| Tanaka, H | 1 |
| Inoshita, S | 1 |
| Kuwahara, M | 1 |
| Sasaki, S | 1 |
| Fiszman, G | 1 |
| Cattaneo, V | 1 |
| de la Torre, E | 1 |
| Español, A | 1 |
| Colombo, L | 1 |
| Sacerdote de Lustig, E | 1 |
| Sales, ME | 1 |
| Sekimoto, G | 1 |
| Uemura, Y | 1 |
| Sakaida, N | 1 |
| Kaibori, M | 1 |
| Kamiyama, Y | 1 |
| Nishizawa, M | 1 |
| Fujisawa, J | 1 |
| Okazaki, K | 1 |
| Seki, T | 1 |
| Makita, S | 1 |
| Nakamura, M | 1 |
| Yoshida, H | 1 |
| Hiramori, K | 1 |
| Vitols, S | 1 |
| Angelin, B | 1 |
| Juliusson, G | 1 |
| Alessandri, G | 1 |
| Cornaglia-Ferraris, P | 1 |
| Gullino, PM | 1 |
| Amadori, D | 1 |
| Silvestrini, R | 1 |
| Hu, X | 1 |
| Guo, Z | 1 |
| Tianyun, P | 1 |
| Pontén, F | 1 |
| Wilander, E | 1 |
| Andersson, S | 1 |
| Pontén, J | 1 |
| Matthews, E | 1 |
| Yang, T | 1 |
| Janulis, L | 1 |
| Goodwin, S | 1 |
| Kundu, SD | 1 |
| Karpus, WJ | 1 |
| Lee, C | 1 |
| Koschmieder, S | 1 |
| Hofmann, WK | 1 |
| Kunert, J | 1 |
| Wagner, S | 1 |
| Ballas, K | 1 |
| Seipelt, G | 1 |
| Hoelzer, D | 1 |
| Ottmann, OG | 1 |
| Kalina, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Could Positon Emission Tomography With Radiolabelled 3'-Deoxy-3'-(18)F-Fluoro-L-Thymidine be a Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patients ?[NCT02069418] | Phase 2 | 80 participants (Anticipated) | Interventional | 2014-02-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thymidine and Disease Exacerbation
| Article | Year |
|---|---|
The impact of human immunodeficiency virus on viral hepatitis.
Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitab | 2011 |
Prognostic and predictive value of thymidine labelling index in breast cancer.
Topics: Breast Neoplasms; Disease Progression; Female; Humans; Predictive Value of Tests; Prognosis; Prospec | 1998 |
4 trials available for thymidine and Disease Exacerbation
| Article | Year |
|---|---|
Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Disease Progression; DNA, Viral; Female; Guanin | 2014 |
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Progression; Erlotinib Hydrochl | 2011 |
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Disease Progression; DNA, Viral; Female; | 2012 |
Simvastatin impairs mitogen-induced proliferation of malignant B-lymphocytes from humans--in vitro and in vivo studies.
Topics: Adult; Aged; B-Lymphocytes; Cell Division; Cholesterol; Chronic Disease; Disease Progression; Dose-R | 1997 |
15 other studies available for thymidine and Disease Exacerbation
| Article | Year |
|---|---|
On-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational study.
Topics: Adult; Aged; alpha-Fetoproteins; Antiviral Agents; Bilirubin; Biomarkers; Disease Progression; Femal | 2013 |
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
Topics: Adult; Age Factors; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Follow | 2014 |
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; DNA, Viral; Female; Hepatit | 2014 |
Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Carbon Radioisotopes; Disease Progression; Female; Fluo | 2015 |
Involvement of thyroid hormones in the alterations of T-cell immunity and tumor progression induced by chronic stress.
Topics: Animals; Cell Proliferation; Concanavalin A; Corticosterone; Disease Models, Animal; Disease Progres | 2009 |
The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy.
Topics: Adaptor Proteins, Signal Transducing; Albuminuria; Animals; Blood Group Antigens; Carrier Proteins; | 2003 |
Expression of B7 molecules in the eye during experimental autoimmune anterior uveitis (EAAU).
Topics: Animals; Antibodies; Antigens; Antigens, CD; Autoimmune Diseases; B7-1 Antigen; B7-2 Antigen; Cattle | 2002 |
Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Blotting, Western; Cell Cycle; Ce | 2005 |
Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
Topics: Adenocarcinoma; Animals; Atropine; Autoantibodies; Blotting, Western; Carbachol; Cell Line, Tumor; C | 2006 |
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Biopsy; Carcinoma, Hepatocellular; Disease Progression; DNA Replication; Hepatit | 2007 |
Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Aorta; Arteriosclerosis; Biphenyl Compounds; Cell | 1995 |
Angiogenic and angiostatic microenvironment in tumors--role of gangliosides.
Topics: Angiogenesis Inducing Agents; Cell Adhesion; Cell Division; Cell Membrane; Collagen; Culture Media; | 1997 |
HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients.
Topics: Adult; Carcinoma, Squamous Cell; Disease Progression; DNA-Binding Proteins; Female; Guanine; Humans; | 1999 |
Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells.
Topics: Animals; Cell Division; Cloning, Molecular; Disease Progression; DNA, Complementary; Down-Regulation | 2000 |
TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.
Topics: Acute Disease; Adult; Antigens, CD34; Cell Division; Disease Progression; DNA Replication; DNA-Bindi | 2001 |